# D003 Thesis — Role-Appropriate Consultant Engagement on Differently-Shaped Decisions ## Claim ATRS applies a single, consistent investment-decision procedural standard, and the apparent Westrock-vs-Israel-Bonds asymmetry is a misreading of two different procedural contexts. White's 5/20/2025 Westrock framing described monitoring-and-sell-recommendation governance over a held public-equity position with active third-party analyst coverage. White's 5/8/2025 Israel Bonds framing described consultant engagement for a sovereign-debt manager-selection decision on a new mandate. These two framings reflect role-appropriate consultant engagement on differently-shaped decisions, not a procedural asymmetry. The differing language reflects the differing investment products and the differing scope of consultant licensure that applies to each, not differing internal standards. The structural rationale White articulated to Jennifer Lenow on 7/2/2025 (the securities-licensure scope of the general investment consultant) is not post-hoc reconstruction; it is the standing operating principle that controls the procedural architecture for both items and reconciles them as instances of the same standard. ## Argument The Westrock context and the Israel Bonds context are not two versions of a single decision class. They are two distinct decision classes that require different consultant roles by the structural design of the consultant engagement. The Westrock decision class is post-acquisition monitoring of a public-equity holding. ATRS already owns the Westrock Coffee position. The question Rollans put to White on 5/19/2025 was a divestment question, not a buy-side question. The procedural standard appropriate to that question is the monitoring-and-sell-recommendation pathway. Investment consultants on public-equity positions monitor the position, maintain communication with the company, and if the analytics warrant a sell, deliver a sell-recommendation to the Board. White's 5/20/2025 reply to Rollans describes precisely that pathway. The standard White invokes is the monitoring pathway operating on a held position with deep third-party analyst coverage. The five Wall Street analysts White cites are not ATRS's consultants. They are independent external coverage of Westrock that supplements the consultant's own monitoring. Their function on the record is to corroborate the consultant's monitoring posture, not to substitute for the consultant's role. The Israel Bonds decision class is a sovereign-debt manager-selection decision on a new mandate. ATRS did not vote on 6/2/2025 to buy specific Israeli sovereigns at specific maturities at specific yields. ATRS voted to authorize a manager (Reams Asset Management) to deploy up to $50 million into Israel Bonds within parameters set by Resolution 2025-22. The decision that went to the Board was a manager-selection decision, plus a deployment-parameter decision. The role-appropriate consultant procedure for a manager-selection decision is a manager-recommendation memo, which Aon supplied through Kelly and Comstock. The role-appropriate consultant procedure for the underlying individual-instrument purchases is no procedure at all on the consultant side, because the consultant does not have the licensure scope to make recommendations on the purchase of individual stocks or bonds. That licensure scope is the structural reason the two framings are different. White's 7/2/2025 Lenow response articulates the controlling principle in unambiguous terms: > "Our general investment consultant's role is to review and make recommendations about investment managers. They never make recommendations about the purchase of individual stocks or bonds. That is not their job, and they would be exceeding the scope of their securities licensure if they were to do so." > Mark White to Jennifer Lenow, Re: [EXTERNAL] Request for comment, 7/2/2025 4:44 PM, captured in auditor-foia-r3-3-3-26 (Brady Inbox FW Request for comment and Milligan Boards Ark Times on Israel Bonds) Under the licensure framing, the question of what Aon does on each decision is determined by the decision shape. On a manager-selection decision, Aon recommends the manager. On an instrument-purchase decision inside a discretionary manager mandate, Aon does not recommend the instrument. The same rule governs both Westrock and Israel Bonds. Apply the rule to Westrock. The monitoring of a held public-equity position is a standing engagement, not a discrete instrument purchase. The sell-versus-hold question for an existing position is the role-appropriate consultant question on a public-equity holding, because divestment of a held position is itself a manager-and-portfolio-level decision affecting how the consultant's recommended allocation translates into actual portfolio composition. White's 5/20 framing of Westrock therefore fits within the licensure scope. The consultant is monitoring the position. If a sell is warranted, the consultant will recommend the sell to the Board. That is a portfolio-composition recommendation, not an individual-instrument-purchase recommendation. It is inside the consultant's licensure. Apply the rule to Israel Bonds. The 6/2/2025 vote was not a vote to buy individual Israeli sovereigns. It was a vote to authorize a manager. The role-appropriate Aon engagement was a manager recommendation. White's 5/8/2025 directive to Graves is therefore not a description of a different procedural standard. It is a description of Aon's licensure-scoped role on a manager-selection-plus-mandate decision: > "I know they will not be making a formal recommendation, but I would like to have some information from them as to the characteristics, performance, and risk profile of these bonds, and to the extent they will do so, some assurance that this is a worthwhile investment." > Mark White to Rod Graves, Emails3.pdf p.6, 5/8/2025, captured in atrs-foia-r1-staff-emails Read inside the licensure framing, the 5/8 directive is a precise disclosure of what Aon will and will not produce. Aon will not produce a recommendation on the individual sovereign-debt instruments because that would exceed Aon's licensure scope. Aon will, to the extent of their licensure scope, produce manager-level analysis on the instrument class characteristics and on whether the mandate is appropriately structured. White's 5/22/2025 Board preview confirms the role-appropriate division of labor by naming the consultant work product that did exist: > "Jason Brady will be making this request on behalf of the Auditor, and we will have advice and materials from Aon on how the investment could be structured." > Mark White Board preview, Emails3.pdf p.28, 5/22/2025, captured in atrs-foia-r1-staff-emails "Advice and materials from Aon on how the investment could be structured" is the role-appropriate consultant work product on a mandate-structuring decision. The 5/28/2025 PJ Kelly transmission of the Reams offer is the role-appropriate consultant work product on the manager-selection decision: > "FYI - a compelling offer from Reams from a few perspective but they are light on experience with Israel bonds but have non-US bond experience and resources." > PJ Kelly to Rod Graves, Emails3.pdf p.31, 5/28/2025, captured in atrs-foia-r1-staff-emails The Kelly transmission shows Aon performing the manager-evaluation function within its licensure scope. Aon evaluated Reams. Aon characterized Reams as "compelling" with the caveat about Israel bonds experience. Aon transmitted the offer with that evaluation attached. That is consultant-as-manager-recommender, which is what the licensure permits. Kelly's 6/2/2025 oral contribution at the Investment Committee meeting confirms the licensure-scoped role: > "That's always a focus like when we bring you managers and strategies but there is a growing area where it's actually investment grade but it's private placements so similar to what like Israel bonds I mean that's investment grade but you know a lot of what you're talking about is sort of private it's not it's a liquid" > PJ Kelly, atrs-ic-audio-6-2-25.transcript.txt segments 2686-2695, [01:32:51 to 01:33:11] Kelly's asset-class classification of Israel Bonds as an "investment grade private placement" is precisely the role-appropriate Aon contribution at the IC stage. It is an instrument-class characterization for asset-allocation purposes, not a buy-recommendation on a specific CUSIP at a specific yield. Kelly speaks to whether the asset class is one Aon brings managers and strategies on. That is licensure-scoped consultant work product, and it is on the IC record at the moment of the vote. The wiki's prior framing of the Kelly contribution as a private-debt-segment side-comment misreads the structural significance. The "investment grade private placement" framing is the asset-class anchor that justifies the manager-selection-on-Reams pathway. White's own IC-stage articulation of the licensure rationale, captured in the 6/2 IC transcript, predates the Lenow response by approximately one month and forecloses the post-hoc-reconstruction reading: > "we received this request we went to AON to get their advice on this I want you to understand in front of AON because of the way that they were licensed the SEC and they can correct me from this state this they cannot recommend individual stocks to bond so they cannot come to you and say you should buy this particular bond or this particular stock for anything their recommendations are on the managers so what they brought to you is they have a recommendation for a manager who would take these funds and make this investment on your behalf" > Mark White, atrs-ic-audio-6-2-25.transcript.txt segments 985-1002, [00:33:51 to 00:34:55] White articulated the licensure-scope structural rationale at the moment of the IC vote, in front of Aon principals, with the offer that the consultants could correct him if he misstated their licensure. The licensure framing is therefore not a defensive reconstruction generated after the Lenow inquiry. It is the operating principle on the record at the moment the IC voted on the manager-selection-and-mandate decision. The Westrock framing is consistent with the same principle. Read inside the licensure framing, White's 5/20 reply describes the consultant performing portfolio-composition monitoring inside licensure scope, supplemented by independent third-party analyst coverage: > "At ATRS our investment decisions are based on recommendations from our outside professional investment consultants. They are monitoring and stay in regular communication with Westrock, and if they determine it is in the System's interest to sell our stake, they will make that recommendation to the Board." > Mark White to John Rollans, Communication with John Rollans - 9 june 2025.pdf p.2, 5/20/2025, captured in auditor-foia-r1-milligan The 5/20 framing is monitoring-and-sell-recommendation language. White is not promising Rollans that the consultant did a buy-side analysis on every Westrock share ATRS holds. White is describing the standing monitoring engagement that operates on the held position. That engagement is inside the consultant's licensure scope because it concerns the portfolio-composition question (hold vs sell the whole position), not an individual-instrument-purchase question. The five Wall Street analysts White cites supplement the consultant's monitoring but do not substitute for it. They are independent third-party coverage that bolsters the hold-recommendation posture. Under this reading, the procedural standard is one standard with two role-appropriate applications. Consultants recommend inside their licensure scope. The licensure scope covers manager selection on new mandates and portfolio-composition monitoring on held positions. The licensure scope does not cover individual-instrument purchase recommendations. The Board receives consultant work product calibrated to the decision shape. On Westrock, the work product is monitoring posture plus sell-recommendation availability if warranted. On Israel Bonds, the work product is a manager recommendation (Reams) plus mandate-structuring advice plus asset-class characterization. Both products are inside licensure. The asymmetry the tension page identifies is an artifact of comparing two role-appropriate procedures on differently-shaped decisions, not a substantive procedural defect. The fiduciary-duty implications follow. Under Act 498's pecuniary standard, the Board fulfilled its obligation on Israel Bonds by relying on the consultant work product inside the consultant's licensure scope plus the executive director's pecuniary judgment on the underlying instrument class. White's 5/22 "From a pecuniary standpoint" framing is not a substitute for consultant analysis. It is the executive director's licensure-permitted judgment on the question the consultant cannot answer by structural design. The procedural record is consistent. The Board followed the standing standard. ## Evidence White's controlling articulation of the licensure-scope principle, 7/2/2025: > "Our general investment consultant's role is to review and make recommendations about investment managers. They never make recommendations about the purchase of individual stocks or bonds. That is not their job, and they would be exceeding the scope of their securities licensure if they were to do so." > Mark White to Jennifer Lenow, 7/2/2025 4:44 PM, captured in auditor-foia-r3-3-3-26 White's process defense, same email, characterizing the Board's Israel Bonds procedure as the standard ATRS fixed-income procedure: > "Last month, the Board selected an investment manager to increase our stake in investment strategies that include bonds issued by the Government of Israel. The Board made this decision with the advice of its general investment consultant and their recommendation of an investment manager. This process — the selection of an investment manager based upon the advice and recommendation of our general investment consultant — is the same way the Board always chooses fixed income investment managers. This is what the Board's policies require." > Mark White to Jennifer Lenow, 7/2/2025 4:44 PM, captured in auditor-foia-r3-3-3-26 White's IC-stage articulation of the licensure rationale at the moment of the vote, predating Lenow: > "we received this request we went to AON to get their advice on this I want you to understand in front of AON because of the way that they were licensed the SEC and they can correct me from this state this they cannot recommend individual stocks to bond so they cannot come to you and say you should buy this particular bond or this particular stock for anything their recommendations are on the managers so what they brought to you is they have a recommendation for a manager who would take these funds and make this investment on your behalf" > Mark White, atrs-ic-audio-6-2-25.transcript.txt segments 985-1002, [00:33:51 to 00:34:55] The 5/8 directive disclosing Aon's licensure-scoped role on the Israel Bonds mandate: > "I know they will not be making a formal recommendation, but I would like to have some information from them as to the characteristics, performance, and risk profile of these bonds, and to the extent they will do so, some assurance that this is a worthwhile investment." > Mark White to Rod Graves, Emails3.pdf p.6, 5/8/2025, captured in atrs-foia-r1-staff-emails The 5/22 Board preview naming the consultant work product on mandate structuring: > "Jason Brady will be making this request on behalf of the Auditor, and we will have advice and materials from Aon on how the investment could be structured." > Mark White Board preview, Emails3.pdf p.28, 5/22/2025, captured in atrs-foia-r1-staff-emails The 5/28 Kelly transmission performing the consultant-as-manager-recommender role: > "FYI - a compelling offer from Reams from a few perspective but they are light on experience with Israel bonds but have non-US bond experience and resources." > PJ Kelly to Rod Graves, Emails3.pdf p.31, 5/28/2025, captured in atrs-foia-r1-staff-emails Kelly's 6/2 IC-stage asset-class characterization of Israel Bonds as a licensure-scoped consultant contribution: > "That's always a focus like when we bring you managers and strategies but there is a growing area where it's actually investment grade but it's private placements so similar to what like Israel bonds I mean that's investment grade but you know a lot of what you're talking about is sort of private it's not it's a liquid" > PJ Kelly, atrs-ic-audio-6-2-25.transcript.txt segments 2686-2695, [01:32:51 to 01:33:11] The 5/20 Westrock framing describing the monitoring-and-sell-recommendation pathway on a held public-equity position: > "At ATRS our investment decisions are based on recommendations from our outside professional investment consultants. They are monitoring and stay in regular communication with Westrock, and if they determine it is in the System's interest to sell our stake, they will make that recommendation to the Board." > Mark White to John Rollans, Communication with John Rollans - 9 june 2025.pdf p.2, 5/20/2025, captured in auditor-foia-r1-milligan The 5/20 reply citing third-party analyst coverage as independent supplement to the consultant's monitoring: > "I'd add that there are 5 analysts on Wall Street who are tracking and making recommendations on Westrock, and all 5 of them have the stock rated as 'buy', meaning they are recommending that their clients purchase Westrock stock." > Mark White to John Rollans, Communication with John Rollans - 9 june 2025.pdf p.2, 5/20/2025, captured in auditor-foia-r1-milligan ## Anticipated counterarguments The antithesis will press three lines. First, that the 5/20 Westrock framing cites five Wall Street analysts and that those analysts are themselves operating on individual-instrument coverage. The thesis acknowledges the citation. The thesis position is that the Wall Street analysts are independent third-party coverage that supplements but does not substitute for ATRS's consultant. They are not invoked as ATRS's consultants. They are invoked as external validation of the consultant's monitoring posture. Second, that the April 7, 2025 ATRS Board packet contains seven substantive consultant memos for seven manager decisions, while the 6/2 packet contains the empty Kelly + Comstock memo on Israel Bonds. The thesis acknowledges the April 7 baseline exists. The thesis position is that the April 7 manager decisions and the 6/2 Israel Bonds manager decision are different in shape (the Israel Bonds mandate has an instrument-class characterization layer the equity, private-credit, and infrastructure mandates do not), and that the relevant Aon work product on the 6/2 decision includes the Kelly mandate-structuring advice plus the Kelly Reams transmission plus the IC-stage asset-class characterization, none of which appear in the packet's Attachment 17 alone. Third, that the IC framings of Aon's role are inconsistent across the record. The thesis acknowledges the surface-level variation. The thesis position is that the variation reflects the differing decision shapes the IC addresses across its agenda, not differing procedural standards. Kelly's 6/2 oral contribution on Israel Bonds is asset-class-characterization work product appropriate to the manager-selection-and-mandate decision shape. The substantive work product is on the record. The procedural standard is consistent. These are flagged but not engaged. The antithesis subagent will press them. This subagent's commitment is to the licensure-scope reading as the controlling principle that reconciles the two framings as a single standard. ## Cross-References [[T003 - Westrock-vs-Israel-Bonds Procedural Standard]] parent tension page [[atrs-foia-r1-staff-emails]] [[auditor-foia-r1-milligan]] [[auditor-foia-r3-3-3-26]] [[atrs-ic-audio-6-2-25]] source pages cited [[westrock-procedural-asymmetry]] [[written-recommendation-requirement]] [[independent-credit-analysis-gap]] synthesis pages this dialectic feeds [[mark-white]] [[pj-kelly]] [[aon-hewitt]] entities central to the licensure-scope framing